{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:00Z","timestamp":1707525120476},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,30]]},"DOI":"10.7759\/cureus.38351","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:14:50Z","timestamp":1682900090000},"source":"Crossref","is-referenced-by-count":0,"title":["A Preliminary Analysis of Ki-67 Expression in Breast Cancer in the Caribbean"],"prefix":"10.7759","author":[{"given":"Akshay","family":"Maharaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarini","family":"Mahase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead","family":"Bhagwandeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levi","family":"Ramcharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riyad","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Ramdass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinash","family":"Deyalsingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"All cancers cancer incidence and mortality statistics worldwide and by region incidence mortality. (2018). Accessed. August 12th 2021: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/39-All-cancers-fact-sheet.pdf."},{"key":"ref2","unstructured":"Cancer incidence and mortality statistics worldwide and by region incidence mortality. (2018). Accessed. August 12th 2021: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/20-Breast-fact-sheet.pdf."},{"key":"ref3","unstructured":"Ranking (Breast), estimated number of deaths in 2020, all ages, Caribbean Hub. (2020). Accessed. August 12th 2021: https:\/\/gco.iarc.fr\/today\/online-analysis-map?v=2020&mode=ranking&mode_population=continents&population=900&populatio...."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910310104","article-title":"Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation","volume":"31","author":"Gerdes J","year":"1983","unstructured":"Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983, 31:13-20. 10.1002\/ijc.2910310104","journal-title":"Int J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa201","article-title":"Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group","volume":"113","author":"Nielsen TO","year":"2021","unstructured":"Nielsen TO, Leung SC, Rimm DL, et al.. Assessment of Ki67 in breast cancer: updated recommendations from the International Ki67 in Breast Cancer Working Group. J Natl Cancer Inst. 2021, 113:808-19. 10.1093\/jnci\/djaa201","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2016.0066","article-title":"Ki-67 as a prognostic marker according to breast cancer molecular subtype","volume":"13","author":"Soliman NA","year":"2016","unstructured":"Soliman NA, Yussif SM. Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer Biol Med. 2016, 13:496-504. 10.20892\/j.issn.2095-3941.2016.0066","journal-title":"Cancer Biol Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2016.2.12285","article-title":"Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients","volume":"37","author":"Elkablawy MA","year":"2016","unstructured":"Elkablawy MA, Albasri AM, Mohammed RA, Hussainy AS, Nouh MM, Alhujaily AS. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients. Saudi Med J. 2016, 37:137-41. 10.15537\/smj.2016.2.12285","journal-title":"Saudi Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4653-x","article-title":"Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters","volume":"12","author":"Hashmi AA","year":"2019","unstructured":"Hashmi AA, Hashmi KA, Irfan M, et al.. Ki67 index in intrinsic breast cancer subtypes and its association with prognostic parameters. BMC Res Notes. 2019, 12:605. 10.1186\/s13104-019-4653-x","journal-title":"BMC Res Notes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-013-2560-8","article-title":"Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry","volume":"139","author":"Inwald EC","year":"2013","unstructured":"Inwald EC, Klinkhammer-Schalke M, Hofst\u00e4dter F, Zeman F, Koller M, Gerstenhauer M, Ortmann O. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat. 2013, 139:539-52. 10.1007\/s10549-013-2560-8","journal-title":"Breast Cancer Res Treat"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0420","article-title":"The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis","volume":"13","author":"Chen X","year":"2017","unstructured":"Chen X, He C, Han D, et al.. The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis. Future Oncol. 2017, 13:843-57. 10.2217\/fon-2016-0420","journal-title":"Future Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57094-3","article-title":"The prognostic and predictive potential of Ki-67 in triple-negative breast cancer","volume":"10","author":"Zhu X","year":"2020","unstructured":"Zhu X, Chen L, Huang B, et al.. The prognostic and predictive potential of Ki-67 in triple-negative breast cancer. Sci Rep. 2020, 10:225. 10.1038\/s41598-019-57094-3","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3233\/BD-219004","article-title":"Gata-3 and KI-67 expression in correlation with molecular subtypes of breast cancer","volume":"40","author":"Husni Cangara M","year":"2021","unstructured":"Husni Cangara M, Miskad UA, Masadah R, Nelwan BJ, Wahid S. Gata-3 and KI-67 expression in correlation with molecular subtypes of breast cancer. Breast Dis. 2021, 40:S27-31. 10.3233\/BD-219004","journal-title":"Breast Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0435-2","article-title":"Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications","volume":"451","author":"Park D","year":"2007","unstructured":"Park D, K\u00e5resen R, Noren T, Sauer T. Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications. Virchows Arch. 2007, 451:11-8. 10.1007\/s00428-007-0435-2","journal-title":"Virchows Arch"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09557-6","article-title":"A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States","volume":"22","author":"Brown J","year":"2022","unstructured":"Brown J, Scardo S, Method M, et al.. A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States. BMC Cancer. 2022, 22:502. 10.1186\/s12885-022-09557-6","journal-title":"BMC Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3212-x","article-title":"Distribution of Ki-67 values within HER2 & ER\/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology","volume":"17","author":"Kurbel S","year":"2017","unstructured":"Kurbel S, Dmitrovi\u0107 B, Marjanovi\u0107 K, Vrbanec D, Jureti\u0107 A. Distribution of Ki-67 values within HER2 & ER\/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology. BMC Cancer. 2017, 17:231. 10.1186\/s12885-017-3212-x","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/148245-a-preliminary-analysis-of-ki-67-expression-in-breast-cancer-in-the-caribbean","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:09Z","timestamp":1707508689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/148245-a-preliminary-analysis-of-ki-67-expression-in-breast-cancer-in-the-caribbean"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,30]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.38351","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,30]]}}}